However, chemokine CCL20 is upregulated in patients with pancreatic cancer and related to advanced T categories (Rubie et al., 2010), and high expression of CXCL5 is associated with shorter OS in hepatocellular and cholangiocarcinoma (Hu et al., 2018). Here, CCL20 is linked to cholangiocarcinoma.